Comparison between centralised and decentralised supply chain of autologous CAR-T therapies: a UK case study based on discrete event simulation
Decentralised (or distributed) manufacturing that takes place close to the point of care has been a manufacturing paradigm of heightened interest within the cell therapy domain due to the product being living cell material and the need for highly monitored and temperature-controlled supply chain, wh...
| Autors principals: | , , , |
|---|---|
| Format: | Journal article |
| Idioma: | English |
| Publicat: |
Elsevier
2021
|